APA (7th ed.) Citation

Eng, V., Lek, D., Sin, S., Feufack-Donfack, L. B., Orban, A., Salvador, J., . . . Popovici, J. (2025). 14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: A randomised, single-centre, open-label efficacy study. Lancet Infectious Diseases, 25(8), 884. https://doi.org/10.1016/S1473-3099(25)00033-7

Chicago Style (17th ed.) Citation

Eng, Virak, et al. "14 Days of High-dose Versus Low-dose Primaquine Treatment in Patients with Plasmodium Vivax Infection in Cambodia: A Randomised, Single-centre, Open-label Efficacy Study." Lancet Infectious Diseases 25, no. 8 (2025): 884. https://doi.org/10.1016/S1473-3099(25)00033-7.

MLA (9th ed.) Citation

Eng, Virak, et al. "14 Days of High-dose Versus Low-dose Primaquine Treatment in Patients with Plasmodium Vivax Infection in Cambodia: A Randomised, Single-centre, Open-label Efficacy Study." Lancet Infectious Diseases, vol. 25, no. 8, 2025, p. 884, https://doi.org/10.1016/S1473-3099(25)00033-7.